Breaking News

Glaxo to Pay $488.7 Million Fine to End China Corruption Probe
Tweet TWEET

Telcare’s Qualcomm-Based CDMA Glucose Meter Certified by Verizon and Unveiled at CES

  Telcare’s Qualcomm-Based CDMA Glucose Meter Certified by Verizon and
  Unveiled at CES

     First mHealth device for diabetes to operate on the Verizon network

2013 International CES

Business Wire

LAS VEGAS -- January 8, 2013

Telcare’s next-generation wireless blood glucose meter – the Telcare BGM® has
now been certified to operate on Verizon’s nationwide cellular network. The
product was developed in collaboration with both Verizon and Qualcomm, Inc.,
and is the first medical device to utilize Qualcomm’s new Internet of
Everything module. Telcare’s product is the first technology to make CDMA
connectivity affordable for consumer-focused medical devices. The product will
be exhibited in Telcare’s booth, located inside the Qualcomm Life Pavilion
#26715 at the 2013 Consumer Electronics Show.

The Telcare product will operate with both Telcare’s FDA-cleared diabetes
management portal and with other soon-to-be released mHealth care management
platforms. By integrating Telcare’s FDA-cleared blood glucose meter and cloud
server to the Verizon network, people with diabetes, their families, and their
health professionals will now be able to integrate real-time measurement of
blood glucose levels with other physiologic parameters, such as weight and
blood pressure.

“Telcare is excited to establish this collaboration as it will enable us to
better support Americans with diabetes, their loved ones, and their medical
caregivers. Moreover, the outstanding cellular coverage afforded nationwide by
Verizon wireless will be particularly valuable in continuously connecting
people with diabetes to their care system,” said Jonathan C. Javitt, M.D.,
M.P.H., Telcare’s CEO and co-founder.

Diabetes mellitus affects 32 million Americans and the Centers for Disease
Control (CDC) estimates that one in three Americans born after 2000 will have
the condition. Although the complications of diabetes can be prevented through
daily monitoring and control of blood sugar, diabetes today accounts for one
in ten healthcare dollars spent in the U.S. and results in needless strokes,
heart attacks, amputations and cases of blindness.

About Telcare, Inc.:

Telcare, Inc. uses cellular technology and social networking to bridge the
last mile between patients with diabetes, their caregivers, and their families
in order to transform the care of chronic illness. The Company’s first
product, a wireless Blood Glucose Monitoring System, was launched in February
2012. Telcare has been awarded two First Place E-Tech awards by CTIA, been
named the MEDTEC startup of the year, been awarded the Triple Tree Award at
the Wireless Life Sciences Alliance and been awarded the 2012 Edison Gold
Award. Telcare’s products have been featured in the Wall Street Journal, the
New York Times, Forbes, Fox News, and numerous other media sources. Telcare is
funded by Sequoia Capital (Menlo Park, CA), the Qualcomm Life Fund (San Diego,
CA), and private investors. The Company was founded in 2009 by Jonathan C.
Javitt, M.D., M.P.H., John R. Dwyer, Jr., and David Bjork. For more
information, visit www.telcare.com.

Telcare BGM is a registered trademark of Telcare, Inc.

Contact:

Telcare, Inc.
Jennifer Kuesel, 240-369-6003 EXT 116
Email: jkuesel@telcare.com
 
Press spacebar to pause and continue. Press esc to stop.